GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FLI1
|
ENSG00000151702.12 | Fli-1 proto-oncogene, ETS transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FLI1 | hg19_v2_chr11_+_128563652_128563689, hg19_v2_chr11_+_128562372_128562397, hg19_v2_chr11_+_128634589_128634685, hg19_v2_chr11_+_128563948_128564003 | 0.66 | 1.9e-28 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.2 | 57.5 | GO:1902846 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
12.1 | 48.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
12.0 | 36.1 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
10.6 | 31.9 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
8.5 | 17.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
8.5 | 25.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
8.2 | 32.8 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
6.7 | 20.1 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
6.2 | 18.5 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
6.2 | 18.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
6.1 | 18.2 | GO:0039513 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
6.0 | 114.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
5.5 | 16.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
5.4 | 16.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
5.4 | 26.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
4.9 | 34.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.9 | 14.6 | GO:0018307 | enzyme active site formation(GO:0018307) |
4.7 | 23.6 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
4.6 | 23.0 | GO:2000402 | negative regulation of lipoprotein oxidation(GO:0034443) negative regulation of lymphocyte migration(GO:2000402) |
4.4 | 13.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
4.4 | 22.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
4.2 | 12.6 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
4.2 | 25.0 | GO:0060613 | fat pad development(GO:0060613) |
4.0 | 16.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
4.0 | 16.0 | GO:0032053 | ciliary basal body organization(GO:0032053) |
3.9 | 15.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
3.8 | 11.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
3.4 | 10.3 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
3.4 | 10.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.3 | 23.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
3.3 | 10.0 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.3 | 3.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
3.2 | 13.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
3.2 | 50.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
3.1 | 9.4 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
3.1 | 12.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
3.1 | 9.3 | GO:0021592 | midbrain-hindbrain boundary morphogenesis(GO:0021555) fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
3.0 | 9.0 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.9 | 23.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
2.8 | 5.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
2.8 | 16.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.7 | 2.7 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
2.7 | 10.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
2.7 | 10.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
2.7 | 24.3 | GO:0006531 | aspartate metabolic process(GO:0006531) |
2.7 | 8.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
2.7 | 8.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
2.7 | 8.0 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
2.7 | 8.0 | GO:0008355 | olfactory learning(GO:0008355) |
2.7 | 23.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.6 | 42.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
2.6 | 7.9 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
2.6 | 10.5 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
2.6 | 5.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
2.6 | 7.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
2.6 | 10.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
2.6 | 5.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
2.5 | 12.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.5 | 15.1 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
2.5 | 5.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
2.5 | 5.0 | GO:0001101 | response to acid chemical(GO:0001101) |
2.5 | 7.4 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
2.5 | 7.4 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
2.4 | 12.1 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
2.4 | 9.6 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
2.4 | 7.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
2.3 | 37.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.3 | 9.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
2.3 | 20.4 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
2.3 | 29.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
2.3 | 4.5 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
2.3 | 9.0 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
2.2 | 6.7 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.2 | 8.9 | GO:1904379 | maintenance of unfolded protein(GO:0036506) protein localization to cytosolic proteasome complex(GO:1904327) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
2.2 | 11.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.2 | 39.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
2.2 | 6.6 | GO:2000282 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
2.2 | 8.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.2 | 6.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
2.1 | 8.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.1 | 12.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.1 | 8.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
2.1 | 4.2 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
2.0 | 6.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
2.0 | 24.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
2.0 | 36.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.0 | 6.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
2.0 | 19.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.0 | 11.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.0 | 7.9 | GO:0019086 | late viral transcription(GO:0019086) |
2.0 | 5.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
2.0 | 9.8 | GO:0033590 | response to cobalamin(GO:0033590) |
2.0 | 5.9 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
2.0 | 9.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.9 | 5.7 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.8 | 24.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.8 | 60.7 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
1.8 | 12.8 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.8 | 16.3 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
1.8 | 19.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
1.8 | 5.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.8 | 14.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.7 | 24.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
1.7 | 26.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.7 | 10.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.7 | 5.2 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
1.7 | 5.1 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
1.7 | 10.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.7 | 6.8 | GO:0001842 | neural fold formation(GO:0001842) |
1.7 | 8.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) glucose 1-phosphate metabolic process(GO:0019255) |
1.7 | 26.6 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
1.7 | 5.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
1.6 | 6.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.6 | 16.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.6 | 19.4 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.6 | 4.8 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.6 | 9.6 | GO:0048863 | stem cell differentiation(GO:0048863) |
1.6 | 4.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.6 | 4.8 | GO:0014028 | mesoderm migration involved in gastrulation(GO:0007509) notochord formation(GO:0014028) |
1.6 | 7.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.5 | 8.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.5 | 4.5 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
1.5 | 10.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.5 | 4.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.4 | 5.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.4 | 9.9 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.4 | 17.0 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
1.4 | 4.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.4 | 11.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.4 | 2.8 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
1.4 | 8.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.3 | 4.0 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
1.3 | 6.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
1.3 | 19.5 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
1.3 | 7.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
1.3 | 30.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.2 | 5.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
1.2 | 10.0 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
1.2 | 2.5 | GO:0060322 | head development(GO:0060322) |
1.2 | 19.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.2 | 6.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.2 | 12.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.2 | 7.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
1.2 | 2.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.2 | 7.2 | GO:0002467 | germinal center formation(GO:0002467) |
1.2 | 3.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.2 | 11.9 | GO:0015889 | cobalamin transport(GO:0015889) |
1.2 | 3.5 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
1.2 | 6.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.1 | 14.9 | GO:0010224 | response to UV-B(GO:0010224) |
1.1 | 2.3 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
1.1 | 5.7 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.1 | 9.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.1 | 4.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.1 | 7.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.1 | 4.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.1 | 3.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.1 | 3.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.1 | 7.7 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
1.1 | 8.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.1 | 2.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.1 | 19.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.0 | 12.4 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
1.0 | 5.2 | GO:1902714 | negative regulation of interleukin-17 production(GO:0032700) negative regulation of interferon-gamma secretion(GO:1902714) |
1.0 | 6.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 5.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.0 | 10.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
1.0 | 7.2 | GO:0051414 | response to cortisol(GO:0051414) |
1.0 | 4.1 | GO:1905007 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
1.0 | 17.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 5.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.0 | 5.0 | GO:0080009 | mRNA methylation(GO:0080009) |
1.0 | 7.0 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
1.0 | 3.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
1.0 | 6.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.0 | 5.8 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.0 | 2.9 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.0 | 2.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
1.0 | 3.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.0 | 8.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.0 | 1.9 | GO:0061511 | centriole elongation(GO:0061511) |
0.9 | 1.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.9 | 9.4 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.9 | 6.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.9 | 8.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.9 | 49.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.9 | 10.0 | GO:0006914 | autophagy(GO:0006914) |
0.9 | 5.4 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.9 | 2.7 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.9 | 5.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 3.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.9 | 4.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.9 | 5.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.9 | 4.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 9.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 2.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.8 | 17.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 20.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.8 | 4.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.8 | 28.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.8 | 8.3 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.8 | 4.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.8 | 6.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.8 | 4.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.8 | 1.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.8 | 2.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.8 | 17.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.8 | 10.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.8 | 2.4 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.8 | 3.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.8 | 3.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.8 | 6.8 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.8 | 27.9 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.8 | 2.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.8 | 0.8 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.7 | 6.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.7 | 28.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.7 | 2.2 | GO:0050894 | determination of affect(GO:0050894) |
0.7 | 3.0 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
0.7 | 8.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.7 | 8.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 4.4 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.7 | 19.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.7 | 6.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.7 | 2.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.7 | 56.1 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.7 | 10.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 5.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 8.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.7 | 11.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.7 | 2.1 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.7 | 7.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 9.7 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.7 | 11.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.7 | 21.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.7 | 6.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.7 | 3.4 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.7 | 24.8 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.7 | 8.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.7 | 4.0 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.7 | 5.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 7.2 | GO:0051972 | regulation of telomerase activity(GO:0051972) positive regulation of telomerase activity(GO:0051973) |
0.7 | 10.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.7 | 1.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.6 | 5.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 4.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 7.7 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) proton-transporting two-sector ATPase complex assembly(GO:0070071) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 3.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.6 | 1.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 6.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.6 | 4.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 1.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.6 | 12.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.6 | 5.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.6 | 3.1 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) |
0.6 | 8.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.6 | 5.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 5.6 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.6 | 1.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.6 | 7.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 2.4 | GO:0060084 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) synaptic transmission involved in micturition(GO:0060084) |
0.6 | 1.2 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.6 | 3.6 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.6 | 1.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
0.6 | 7.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 1.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.6 | 3.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.6 | 1.7 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.6 | 1.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.6 | 2.9 | GO:0032456 | endocytic recycling(GO:0032456) |
0.6 | 7.3 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.6 | 1.7 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.6 | 3.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.6 | 21.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.5 | 3.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 4.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.5 | 1.6 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.5 | 7.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.5 | 9.7 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.5 | 7.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 9.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 3.7 | GO:0042426 | choline catabolic process(GO:0042426) |
0.5 | 3.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 4.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 8.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 4.1 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.5 | 5.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 3.0 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.5 | 13.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.5 | 22.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.5 | 2.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 3.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 8.1 | GO:0050890 | cognition(GO:0050890) |
0.5 | 16.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.5 | 1.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 9.9 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.5 | 44.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.5 | 5.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 19.7 | GO:0032608 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.5 | 2.0 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.5 | 2.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.5 | 6.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 2.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.5 | 2.9 | GO:0033504 | floor plate development(GO:0033504) |
0.5 | 7.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.5 | 1.9 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.5 | 11.3 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.5 | 2.3 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.5 | 1.4 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.5 | 3.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.5 | 5.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.5 | 4.1 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.4 | 2.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 2.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 2.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 6.6 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.4 | 2.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.4 | 6.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.4 | 2.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 3.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.4 | 9.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.4 | 27.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.4 | 5.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 8.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 3.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 9.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 2.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 4.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.4 | 6.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 5.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.4 | 3.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.4 | 0.8 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 17.4 | GO:0070206 | protein trimerization(GO:0070206) |
0.4 | 5.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.4 | 5.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 4.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 3.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.4 | 9.8 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 2.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.4 | 4.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 4.6 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 7.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 3.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.3 | 1.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.3 | 5.7 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.3 | 2.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 6.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 20.2 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.3 | 3.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 2.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 2.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 1.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 1.6 | GO:0030035 | microspike assembly(GO:0030035) glomerulus morphogenesis(GO:0072102) |
0.3 | 9.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 0.6 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.3 | 4.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 4.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 7.6 | GO:0048265 | response to pain(GO:0048265) |
0.3 | 11.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.3 | 3.6 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.3 | 2.7 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.3 | 7.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.3 | 28.5 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 1.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.3 | 25.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 4.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 4.1 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.3 | 3.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 11.5 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.3 | 11.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.3 | 2.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 2.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.3 | 0.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 3.1 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 8.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 18.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 6.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 7.6 | GO:0003014 | renal system process(GO:0003014) |
0.3 | 2.4 | GO:0060346 | sequestering of TGFbeta in extracellular matrix(GO:0035583) bone trabecula formation(GO:0060346) |
0.3 | 2.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 2.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 16.2 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.3 | 2.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 2.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 1.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 1.7 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 2.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 1.9 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 6.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 1.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 5.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 6.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 3.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 1.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 2.0 | GO:1903747 | regulation of establishment of protein localization to mitochondrion(GO:1903747) |
0.2 | 4.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 | 6.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 4.8 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.2 | 3.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 8.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 3.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 1.9 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
0.2 | 6.5 | GO:0042116 | macrophage activation(GO:0042116) |
0.2 | 1.4 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.2 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 5.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 16.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 3.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 5.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.2 | 8.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 4.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 2.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.2 | 1.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 5.2 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 2.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 1.0 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 3.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 2.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 1.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 4.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 1.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 2.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 2.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 1.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 8.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 2.9 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 10.3 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 4.4 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 1.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 4.1 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 6.7 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 2.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 4.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.4 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 2.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 1.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 2.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 6.9 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 1.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 2.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 9.7 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 11.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 1.2 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.6 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 1.9 | GO:0070849 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.7 | GO:0090045 | protein farnesylation(GO:0018343) positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.4 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 4.2 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 3.5 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 1.8 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 14.8 | GO:0007411 | axon guidance(GO:0007411) |
0.1 | 9.9 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.1 | 9.2 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 | 1.3 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) centromere complex assembly(GO:0034508) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 6.0 | GO:0007588 | excretion(GO:0007588) |
0.1 | 1.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 2.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 3.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 1.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 3.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.9 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 1.9 | GO:0042278 | purine nucleoside metabolic process(GO:0042278) |
0.1 | 4.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 1.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 3.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 1.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 5.1 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 3.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.7 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 2.8 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 2.7 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 2.8 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 1.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 2.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 2.8 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 1.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 1.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 1.2 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.0 | 1.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 1.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 2.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 1.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.4 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) angiotensin maturation(GO:0002003) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 2.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.9 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 1.2 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.9 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 1.7 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 1.4 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 0.2 | GO:0042552 | myelination(GO:0042552) |
0.0 | 0.1 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 1.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.2 | 57.5 | GO:0061673 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
16.2 | 48.5 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
10.9 | 65.4 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
9.0 | 36.1 | GO:1990745 | EARP complex(GO:1990745) |
6.5 | 19.4 | GO:0044609 | DBIRD complex(GO:0044609) |
5.2 | 41.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
4.9 | 19.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
4.2 | 4.2 | GO:0098536 | deuterosome(GO:0098536) |
4.0 | 20.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
3.9 | 19.5 | GO:0070847 | core mediator complex(GO:0070847) |
3.8 | 19.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
3.8 | 37.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.5 | 24.3 | GO:0097427 | microtubule bundle(GO:0097427) |
3.4 | 23.6 | GO:0033269 | internode region of axon(GO:0033269) |
3.2 | 22.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.6 | 10.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.5 | 20.3 | GO:0032010 | phagolysosome(GO:0032010) |
2.5 | 4.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
2.3 | 9.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
2.2 | 15.6 | GO:0044194 | cytolytic granule(GO:0044194) |
2.1 | 10.4 | GO:0045298 | tubulin complex(GO:0045298) |
2.0 | 22.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.0 | 10.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.9 | 42.9 | GO:0000242 | pericentriolar material(GO:0000242) |
1.9 | 26.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.9 | 9.3 | GO:0089701 | U2AF(GO:0089701) |
1.7 | 38.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.7 | 30.8 | GO:0097342 | ripoptosome(GO:0097342) |
1.7 | 5.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
1.7 | 5.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.7 | 5.0 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
1.6 | 9.4 | GO:1990037 | Lewy body core(GO:1990037) |
1.5 | 10.3 | GO:0032584 | growth cone membrane(GO:0032584) |
1.5 | 5.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.4 | 24.6 | GO:0033270 | paranode region of axon(GO:0033270) |
1.4 | 8.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.4 | 9.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
1.4 | 19.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.4 | 51.1 | GO:0042629 | mast cell granule(GO:0042629) |
1.4 | 15.1 | GO:0097443 | sorting endosome(GO:0097443) |
1.4 | 4.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
1.3 | 4.0 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
1.3 | 8.0 | GO:1990130 | Iml1 complex(GO:1990130) |
1.2 | 10.0 | GO:0000322 | storage vacuole(GO:0000322) |
1.2 | 7.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
1.2 | 17.0 | GO:0035102 | PRC1 complex(GO:0035102) |
1.2 | 3.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.2 | 5.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.1 | 7.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.1 | 7.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 57.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.1 | 2.1 | GO:0032009 | early phagosome(GO:0032009) |
1.1 | 9.5 | GO:0032039 | integrator complex(GO:0032039) |
1.1 | 5.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 5.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.0 | 10.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.0 | 34.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
1.0 | 6.9 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 16.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.9 | 10.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.9 | 5.2 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.9 | 7.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.8 | 12.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.8 | 10.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.8 | 5.0 | GO:0005770 | late endosome(GO:0005770) |
0.8 | 8.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.8 | 9.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.8 | 5.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.8 | 4.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.7 | 19.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.7 | 7.4 | GO:0012506 | vesicle membrane(GO:0012506) |
0.7 | 2.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 2.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.7 | 38.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.7 | 2.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.7 | 6.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 3.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.7 | 37.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 7.7 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 4.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 9.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.6 | 8.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.6 | 6.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 7.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 6.3 | GO:0032797 | SMN complex(GO:0032797) |
0.6 | 2.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 7.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.5 | 5.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 3.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 4.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 2.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 0.9 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.5 | 33.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 10.7 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 14.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 2.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 12.6 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.4 | 21.4 | GO:0031904 | endosome lumen(GO:0031904) |
0.4 | 2.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 3.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 6.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 4.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 20.2 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.4 | 3.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 5.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 9.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 3.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 3.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 3.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 7.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 5.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 4.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.3 | 7.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 3.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 5.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 4.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 5.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 3.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 3.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 4.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 25.4 | GO:0005814 | centriole(GO:0005814) |
0.3 | 4.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 5.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 4.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 3.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.9 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.2 | 0.7 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.2 | 45.0 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 1.1 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.2 | 18.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 36.1 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 3.4 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.2 | 7.5 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 16.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 10.4 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 1.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.8 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 0.6 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 3.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 10.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 4.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 3.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 11.0 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 22.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 1.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 31.9 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 0.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 7.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 5.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 7.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 9.1 | GO:0005768 | endosome(GO:0005768) |
0.1 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 27.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 12.4 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 2.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 2.0 | GO:0032059 | bleb(GO:0032059) |
0.1 | 26.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 2.9 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 2.0 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 13.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 32.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 393.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 4.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 5.6 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 2.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 16.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 1.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 3.2 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 1.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 2.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 2.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.7 | 103.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
9.8 | 29.4 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
9.3 | 65.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
8.5 | 25.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
8.1 | 24.3 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
7.5 | 44.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
7.2 | 7.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
5.7 | 11.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
5.5 | 16.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
5.1 | 61.6 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
4.8 | 23.9 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
4.6 | 18.5 | GO:0032810 | sterol response element binding(GO:0032810) |
4.3 | 21.4 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
4.3 | 55.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
4.2 | 12.6 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
4.1 | 16.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
3.7 | 29.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
3.6 | 14.6 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
3.6 | 10.9 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
3.5 | 10.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.4 | 61.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
3.4 | 10.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
3.3 | 9.9 | GO:0032089 | NACHT domain binding(GO:0032089) |
3.1 | 22.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
3.1 | 36.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.0 | 12.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
3.0 | 56.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.6 | 7.9 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
2.6 | 10.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
2.6 | 7.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.5 | 10.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
2.5 | 40.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
2.5 | 7.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.4 | 14.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.4 | 14.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
2.3 | 13.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.2 | 6.7 | GO:0016297 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
2.2 | 6.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.2 | 15.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.2 | 6.6 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
2.2 | 39.6 | GO:0005522 | profilin binding(GO:0005522) |
2.2 | 23.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.1 | 8.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
2.1 | 12.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
2.1 | 4.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.0 | 6.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
2.0 | 20.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.0 | 24.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
2.0 | 7.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.9 | 15.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.9 | 11.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.9 | 32.0 | GO:0070513 | death domain binding(GO:0070513) |
1.9 | 9.4 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
1.9 | 9.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.8 | 20.3 | GO:0030274 | LIM domain binding(GO:0030274) |
1.7 | 5.2 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.7 | 5.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.7 | 5.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
1.7 | 5.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.7 | 5.0 | GO:0004040 | amidase activity(GO:0004040) |
1.7 | 5.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.7 | 8.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.6 | 9.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
1.6 | 11.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.6 | 6.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.5 | 10.8 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.5 | 28.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.5 | 11.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.5 | 4.4 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.5 | 4.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
1.4 | 4.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.4 | 12.7 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) lysophosphatidic acid receptor activity(GO:0070915) |
1.4 | 12.6 | GO:0003680 | AT DNA binding(GO:0003680) |
1.4 | 6.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.4 | 8.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.4 | 59.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.4 | 30.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.4 | 59.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.4 | 20.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.3 | 6.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.3 | 16.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.3 | 7.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.3 | 150.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.3 | 3.8 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.3 | 12.8 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
1.3 | 3.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.2 | 5.0 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
1.2 | 8.6 | GO:0031730 | CCR1 chemokine receptor binding(GO:0031726) CCR5 chemokine receptor binding(GO:0031730) |
1.2 | 6.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.2 | 17.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.2 | 20.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.1 | 4.6 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
1.1 | 3.4 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
1.1 | 4.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.1 | 10.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 3.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
1.0 | 5.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.0 | 3.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.0 | 5.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.0 | 18.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.0 | 12.1 | GO:0045159 | myosin II binding(GO:0045159) |
1.0 | 7.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.0 | 8.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 2.9 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
1.0 | 3.9 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
1.0 | 3.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 3.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 3.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.9 | 10.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.9 | 15.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.9 | 3.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.9 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.9 | 4.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.9 | 13.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.9 | 5.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.9 | 2.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.9 | 5.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.9 | 7.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.8 | 5.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.8 | 11.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 13.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 5.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 3.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 71.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.8 | 16.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.8 | 7.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.8 | 37.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.7 | 2.2 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.7 | 10.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 4.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 9.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.7 | 2.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.7 | 3.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.7 | 3.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.7 | 6.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.7 | 6.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 8.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.7 | 3.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 14.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.7 | 11.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 2.0 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.7 | 7.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 3.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 9.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 4.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.6 | 4.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 3.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 3.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 2.4 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.6 | 9.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 17.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.6 | 8.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 6.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.6 | 25.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 3.5 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.6 | 13.5 | GO:0071949 | FAD binding(GO:0071949) |
0.6 | 4.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 17.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.6 | 4.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 3.3 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 26.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.5 | 6.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 2.1 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 3.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 3.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.5 | 4.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) galactose binding(GO:0005534) |
0.5 | 6.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 10.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.5 | 2.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 14.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 10.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 2.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 6.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 5.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 6.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 2.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.4 | 5.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.4 | 4.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 9.9 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.4 | 1.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 39.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.4 | 1.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 11.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 8.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 11.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 1.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.4 | 2.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 6.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.4 | 1.6 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.4 | 7.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 14.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 9.7 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 9.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 6.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 3.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 1.1 | GO:0031692 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) platelet activating factor receptor binding(GO:0031859) |
0.4 | 9.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 8.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 1.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 21.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 8.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 3.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 11.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 13.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.3 | 1.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 5.9 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 7.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 10.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 3.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 11.3 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 3.9 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 10.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.3 | 1.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 1.9 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.3 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 2.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 10.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 3.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 3.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 2.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.3 | 7.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 5.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 4.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.9 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.3 | 15.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 26.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.3 | 4.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 2.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 6.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 2.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 4.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 2.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 2.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 8.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 5.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 2.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 6.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 3.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 4.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 7.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 2.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 70.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 5.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 2.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 5.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 0.9 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.2 | 1.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 3.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 4.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 7.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 4.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 4.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 7.6 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 188.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 46.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 2.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 2.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 11.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 43.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 16.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 5.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 1.9 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 1.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 3.3 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 4.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 3.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 7.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.7 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 3.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 5.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 8.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 42.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 2.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 21.5 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 2.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 2.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 29.7 | GO:0004888 | transmembrane signaling receptor activity(GO:0004888) |
0.1 | 1.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 6.6 | GO:0046873 | metal ion transmembrane transporter activity(GO:0046873) |
0.1 | 1.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 1.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 2.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 2.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 1.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 4.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 13.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.2 | 128.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.9 | 17.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.8 | 91.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.6 | 162.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.5 | 21.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.4 | 73.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.4 | 77.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.4 | 89.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.3 | 89.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.0 | 17.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.0 | 13.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.8 | 7.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 30.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 3.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.8 | 0.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 18.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 19.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.7 | 28.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 11.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 6.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 20.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 19.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.6 | 3.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 26.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 24.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 24.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 13.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 16.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 14.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 9.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 14.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 63.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 6.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 5.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 6.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 19.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 117.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 6.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 6.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 18.1 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 9.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 4.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 3.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 2.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 7.0 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 13.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 4.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 3.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 2.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 16.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 7.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 2.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 7.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 9.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 24.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 6.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 57.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
2.9 | 60.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.7 | 62.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.0 | 33.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.9 | 5.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.5 | 48.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.5 | 69.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.2 | 109.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.1 | 19.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.1 | 48.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.1 | 4.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.1 | 9.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.1 | 14.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.1 | 11.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.8 | 9.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.8 | 15.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 9.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.8 | 9.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.8 | 19.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.7 | 2.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 21.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 1.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 20.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.7 | 47.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 11.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.6 | 6.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 20.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.6 | 6.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 8.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.6 | 11.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 35.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.6 | 21.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.6 | 4.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 12.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 32.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 33.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 2.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 3.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 9.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 2.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.5 | 9.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 11.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 17.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 83.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 9.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 7.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 10.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 30.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 9.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 15.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 2.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 4.8 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.4 | 12.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 7.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 36.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 3.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.4 | 6.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.4 | 17.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 4.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 9.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 5.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 101.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 6.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 26.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 81.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 1.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 7.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 7.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 3.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 11.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 3.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 5.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 1.4 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 3.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 5.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 4.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 0.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 19.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 8.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 2.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 9.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 4.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 2.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 5.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 5.9 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 2.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 2.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |